申请人:Gilead Sciences, Inc.
公开号:US20140221286A1
公开(公告)日:2014-08-07
It is discovered that sodium-channel blockers inhibit the secretion of glucagon from pancreatic alpha cells. The present disclosure, based on such discoveries, provides compositions and methods for the treatment of hyperglycemia and related diseases and conditions with Na-channel blockers.